Khurana, Surender <br/><br/>
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.  [electronic resource] 

 -  Science translational medicine  Jan 2010 
 - 15ra5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.3000624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adsorption--drug effects<br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Neutralizing--immunology<br/>Antibodies, Viral--immunology<br/>Antibody Formation--drug effects<br/>Birds--immunology<br/>Disease Outbreaks--prevention & control<br/>Epitopes--chemistry<br/>Humans<br/>Hydrogen-Ion Concentration--drug effects<br/>Influenza A Virus, H5N1 Subtype--drug effects<br/>Influenza Vaccines--immunology<br/>Influenza in Birds--epidemiology<br/>Influenza, Human--epidemiology<br/>Kinetics<br/>Models, Molecular<br/>Peptide Library<br/>Polysorbates--pharmacology<br/>Protein Folding--drug effects<br/>Protein Structure, Tertiary<br/>Squalene--immunology<br/>Vaccination